Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALENTINE-PTCL01
NCT04703192Phase 2Active, not recruiting
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of valemetostat in peripheral T-cell lymphoma (PTCL), adult T-cell leukemia-lymphoma (ATLL), sponsored by Daiichi Sankyo Co., Ltd.. Started Jun 2021; status: active, not recruiting.
02
Drugs
valemetostat
03
Conditions
peripheral T-cell lymphoma (PTCL)adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT04703192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04703192.